Canine Lepto*4(Orig S-P Us) Kb
194 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
194
Total Reports
32
Deaths Reported
1650.0%
Death Rate
Active Ingredients
Canine Lepto*4(Orig S-P Us) Kb
Administration Routes
SubcutaneousUnknown
Species Affected
Dog 194
Most Affected Breeds
Crossbred Canine/dog 56
Retriever - Labrador 17
Bulldog - French 7
Siberian Husky 6
Shepherd Dog - Australian 6
Chihuahua 5
Shih Tzu 5
Shepherd Dog - German 5
Maltese 5
Retriever - Golden 5
Most Reported Reactions
Vomiting 50
Emesis (multiple) 40
Lethargy (see also Central nervous system depression in 'Neurological') 37
Anorexia 23
Diarrhoea 22
Death by euthanasia 21
Other abnormal test result NOS 19
Neutrophilia 17
Fever 16
Lethargy (see also Central nervous system depression in Neurological) 16
Elevated alanine aminotransferase (ALT) 13
Not eating 13
Outcome Breakdown
Ongoing
75 (38.7%)
Recovered/Normal
67 (34.5%)
Euthanized
21 (10.8%)
Outcome Unknown
13 (6.7%)
Died
11 (5.7%)
Recovered with Sequela
7 (3.6%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.